Exelixis (EXEL) EBT (2010 - 2026)
Exelixis (EXEL) recorded quarterly EBT of $267.7 million in Q2 2026, up 5.94% quarter-over-quarter from $252.7 million in Q1 2026, and up 30.14% on a YoY basis from $205.7 million in Q2 2025.
Exelixis (EXEL) EBT (2010 - 2026) Analysis & Trends
Exelixis' EBT history runs 17 years deep, the most recent figure standing at $267.7 million for Q2 2026.
- In Q2 2026, EBT rose 30.14% year-over-year to $267.7 million; the TTM figure through Apr 2026 stood at $1.0 billion (up 19.7% YoY), while the FY2026 annual figure was $941.2 million, up 38.08% from the prior year.
- EBT was $267.7 million for Q2 2026 at Exelixis, up from $252.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of $292.8 million in Q2 2024 to a low of -$31.4 million in Q4 2022.
- Historically, EBT has averaged $140.1 million across 5 years, with a median of $103.0 million in 2023.
- Biggest YoY gain for EBT was 4329.73% in 2022; the steepest drop was 126.63% in 2022.
- A 5-year view of EBT shows it stood at -$31.4 million in 2022, then surged by 427.87% to $103.0 million in 2023, then soared by 50.19% to $154.8 million in 2024, then surged by 63.1% to $252.4 million in 2025, then climbed by 6.05% to $267.7 million in 2026.
- The last three EBT figures came in at $267.7 million (Q2 2026), $252.7 million (Q1 2026), and $252.4 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.48 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 267.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 267.69 Mn |
| Jan 2, 2026 | 252.69 Mn |
| Oct 3, 2025 | 252.41 Mn |
| Jul 4, 2025 | 230.42 Mn |
| Apr 4, 2025 | 205.69 Mn |
| Jan 3, 2025 | 184.77 Mn |
| Sep 27, 2024 | 154.76 Mn |
| Jun 28, 2024 | 292.85 Mn |
| Mar 29, 2024 | 49.27 Mn |
| Dec 29, 2023 | 103.04 Mn |
| Sep 29, 2023 | 5.82 Mn |
| Jun 30, 2023 | 100.39 Mn |
| Mar 31, 2023 | 48.28 Mn |
| Dec 30, 2022 | -31.43 Mn |
| Sep 30, 2022 | 92.04 Mn |
| Jul 1, 2022 | 88.51 Mn |
| Apr 1, 2022 | 85.23 Mn |
| Dec 31, 2021 | 118.02 Mn |
| Oct 1, 2021 | 53.26 Mn |
| Jul 2, 2021 | 124.89 Mn |